Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease

被引：0

作者：

Zaccagna, A

Bertone, A

Puiatti, P

Picciotto, F

Sprujevnik, T

Santucci, R

Rossini, FP

机构：

[1] IRCC, Inst Canc Res & Treatment, Operat Unit Dermatol Surg, I-10060 Candiolo, Italy

[2] Hosp S Giovanni AS, Dept Oncol, Unit Gastroenterol Endoscopy, I-10123 Turin, Italy

来源：

EUROPEAN JOURNAL OF DERMATOLOGY | 2003年 / 13卷 / 03期

关键词：

Crohns disease; infliximab; neutrophilic dermatoses; Pyoderma gangrenosum; therapy; tumor-necrosis-factor-alpha;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Here we report a case of Pyoderma gangrenosum (PG) associated with Crohn's disease successfully treated with infliximab. The efficacy of this drug in many inflammatory diseases has already been reported, but its use in PG has only been seen in very few cases. Our study confirms that this therapy is a valid alternative solution for treating PG, which is often unresponsive to conventional therapies.

引用

页码：258 / 260

页数：3

共 50 条

[31] Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease
Buisson, Anthony
Cannon, Lisa
Umanskiy, Konstantin
Hurst, Roger D.
Hyman, Neil H.
Sakuraba, Atsushi
Pekow, Joel
Dalal, Sushila
Cohen, Russell D.
Pereira, Bruno
Rubin, David T.
INTESTINAL RESEARCH, 2022, 20 (03) : 303 - +
[32] Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum
Triantafillidis, JK
Cheracakis, P
Sklavaina, M
Apostolopoulou, K
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (07) : 863 - 865
[33] Neurological adverse events associated with anti-tumor necrosis factor alpha treatment
Tristano, Antonio G.
JOURNAL OF NEUROLOGY, 2010, 257 (09) : 1421 - 1431
[34] Multiple sclerosis as an adverse effect of anti-tumor necrosis factor agents: an infrequent but important complication of infliximab in Crohn's disease
Mir Subias, Alberto
Garcia-Lopez, Santiago
Sebastian Torres, Berta
Ollero Domenche, Leticia
Garcia Gamez, Andres
Gomollon, Fernando
GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (02): : 81 - 85
[35] Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti-Tumor Necrosis Factor-α Agents
Kestens, Christine
van Oijen, Martijn G. H.
Mulder, Charlotte L. J.
van Bodegraven, Ad A.
Dijkstra, Gerard
de Jong, Dirk
Ponsioen, Cyriel
van Tuyl, Bas A. C.
Siersema, Peter D.
Fidder, Herma H.
Oldenburg, Bas
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) : 826 - 831
[36] Bamboo Joint-Like Appearance of the Stomach: A Stable Endoscopic Landmark for Crohn's Disease Regardless of Anti-Tumor Necrosis Factor alpha Treatment
Hashiguchi, Keiichi
Takeshima, Fuminao
Akazawa, Yuko
Matsushima, Kayoko
Minami, Hitomi
Yamaguchi, Naoyuki
Shiozawa, Ken
Ohnita, Ken
Ichikawa, Tatsuki
Isomoto, Hajime
Nakao, Kazuhiko
MEDICAL SCIENCE MONITOR, 2014, 20 : 1918 - 1924
[37] Anti-Tumor Necrosis Factor-Alpha-Loaded Microspheres as a Prospective Novel Treatment for Crohn's Disease Fistulae
Foong, Keen Shawn
Patel, Rishni
Forbes, Alastair
Day, Richard M.
TISSUE ENGINEERING PART C-METHODS, 2010, 16 (05) : 855 - 864
[38] Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn’s Disease
Seema A. Patil
Mark H. Flasar
Jay Lin
Melissa Lingohr-Smith
Martha Skup
Song Wang
Jingdong Chao
Raymond K. Cross
Digestive Diseases and Sciences, 2019, 64 : 60 - 67
[39] Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis
Seven, Gulseren
Assaad, Adel
Biehl, Thomas
Kozarek, Richard A.
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (36) : 5135 - 5137
[40] Adalimumab Treatment for Peristomal Pyoderma Gangrenosum Associated with Crohn's Disease
Alkhouri, Naim
Hupertz, Vera
Mahajan, Lori
INFLAMMATORY BOWEL DISEASES, 2009, 15 (06) : 803 - 806

← 1 2 3 4 5 →